| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/05/2001 | WO2000029578A9 Cloning and characterization of two m-rna transcription factors |
| 04/05/2001 | WO2000020450A9 Calcium channel alpha-2/delta gene |
| 04/05/2001 | WO2000014248A9 Cyclic nucleotide-associated proteins |
| 04/05/2001 | WO2000009120A8 New use of taxoid derivatives |
| 04/05/2001 | WO1999060126A9 Protein z-dependent protease inhibitor |
| 04/05/2001 | DE19948644A1 New peptaibol peptides produced by Sepedonium fungus, useful as antibacterial, antifungal, neuroleptic and anxiolytic agents |
| 04/05/2001 | DE19947176A1 Determining the structure of human antigens from antibody binding, useful for diagnosis of e.g. rheumatoid arthritis and development of therapies |
| 04/05/2001 | DE19947010A1 Das Gen PRV-1 und dessen Verwendung The PRV-1 gene and its use |
| 04/05/2001 | DE19943177A1 Verfahren zur Herstellung von aktiven Serienproteasen und inaktiven Varianten A process for the production of active and inactive variants series proteases |
| 04/05/2001 | CA2389203A1 Human secretory molecules |
| 04/05/2001 | CA2388055A1 Immunostimulatory nucleic acids |
| 04/05/2001 | CA2388025A1 Therapy with 2-5a and interferon |
| 04/05/2001 | CA2388005A1 Low dose ifn-gamma for treatment of disease |
| 04/05/2001 | CA2387702A1 The prv-1 gene and use thereof |
| 04/05/2001 | CA2386346A1 Novel polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | CA2386064A1 Estrogen related receptor, err.alpha., a regulator of bone formation |
| 04/05/2001 | CA2386032A1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | CA2386002A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | CA2385989A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | CA2385887A1 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 04/05/2001 | CA2385884A1 26 human secreted proteins |
| 04/05/2001 | CA2385883A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | CA2385880A1 Novel human organic anion transporter-like proteins and polynucleotides encoding the same |
| 04/05/2001 | CA2385791A1 Molecules for disease detection and treatment |
| 04/05/2001 | CA2385743A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | CA2385498A1 Method to enhance healing of sternum after sternotomy |
| 04/05/2001 | CA2385454A1 Viscosity modulating substance and use thereof |
| 04/05/2001 | CA2385252A1 Anti cancer agent and method of treatment of cancer |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2384981A1 P-glycoproteins and uses thereof |
| 04/05/2001 | CA2384662A1 41 human secreted proteins |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/05/2001 | CA2384584A1 38 human secreted proteins |
| 04/05/2001 | CA2382808A1 22196, a novel human aminopeptidase |
| 04/05/2001 | CA2381771A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/05/2001 | CA2379604A1 Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use |
| 04/04/2001 | EP1088900A1 Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications |
| 04/04/2001 | EP1088890A2 Recombinant BPI proteins, uses of BPI proteins, and methods of preparing same |
| 04/04/2001 | EP1088830A2 Hepatitis b surface antigen particles |
| 04/04/2001 | EP1088824A2 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 04/04/2001 | EP1088556A1 Medicinal compositions containing fibroblast growth factor-related peptides |
| 04/04/2001 | EP1088555A1 Sustained-release preparation |
| 04/04/2001 | EP1088107A1 Absorptive hypercalciuria locus on human chromosome 1 |
| 04/04/2001 | EP1088100A2 Proteasomal activity |
| 04/04/2001 | EP1088088A1 Diacylglycerol o-acyltransferase |
| 04/04/2001 | EP1088086A1 Tissue-specific and target rna-specific ribozymes |
| 04/04/2001 | EP1088084A2 Erythropoietin analog-human serum albumin fusion protein |
| 04/04/2001 | EP1088079A2 Nek-related and bub1-related protein kinases |
| 04/04/2001 | EP1088075A2 Aav scleroprotein, production and use thereof |
| 04/04/2001 | EP1088074A1 Origin of replication and methods of use |
| 04/04/2001 | EP1088072A2 Prostate cancer-associated genes |
| 04/04/2001 | EP1088071A1 94 human secreted proteins |
| 04/04/2001 | EP1088070A2 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions |
| 04/04/2001 | EP1088069A1 Angiostatin-binding protein |
| 04/04/2001 | EP1088067A1 Methods and compositions for modulating spermatogenesis |
| 04/04/2001 | EP1088066A1 Antisense oligonucleotide constructs based on beta-arabinofuranose and its analogues |
| 04/04/2001 | EP1088065A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
| 04/04/2001 | EP1088062A1 Transplants for myocardial scars |
| 04/04/2001 | EP1088056A1 A method for in vitro maturation of human gametes |
| 04/04/2001 | EP1087998A1 Variant type ii tgf-beta receptor fusion proteins and methods |
| 04/04/2001 | EP1087997A2 Monoclonal antibodies directed against the g3bp protein, and uses |
| 04/04/2001 | EP1087996A2 Glycosulfopeptides and methods of synthesis and use thereof |
| 04/04/2001 | EP1087994A1 INTERACTION OF p27(KIP1) WITH FKBP-12 |
| 04/04/2001 | EP1087992A1 Antithrombotic compounds |
| 04/04/2001 | EP1087991A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 04/04/2001 | EP1087985A1 Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx |
| 04/04/2001 | EP1087984A2 acpS |
| 04/04/2001 | EP1087981A2 Prenyl transferase inhibitors |
| 04/04/2001 | EP1087935A1 Anthracene derivatives as anti-cancer agents |
| 04/04/2001 | EP1087792A1 NrdD |
| 04/04/2001 | EP1087787A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 04/04/2001 | EP1087785A2 Combination of radiotherapy and anti-angiogenic factors |
| 04/04/2001 | EP1087784A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
| 04/04/2001 | EP1087783A2 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF $i(HELICOBACTER PYLORI)-ASSOCIATED DISORDERS |
| 04/04/2001 | EP1087782A1 Regulation of tyrosine hydroxylase |
| 04/04/2001 | EP1087778A1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c |
| 04/04/2001 | EP1087775A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
| 04/04/2001 | EP1087762A1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
| 04/04/2001 | EP1087756A1 Particulate acellular tissue matrix |
| 04/04/2001 | EP1087753A1 Targeted liposomal drug delivery system |
| 04/04/2001 | EP1087751A1 Active ingredient delivery systems and devices based on porous matrices |
| 04/04/2001 | EP0939767A4 Modified factor viii |
| 04/04/2001 | EP0788515B1 Non-antigenic branched polymer conjugates |
| 04/04/2001 | EP0778921B1 Pumping device |
| 04/04/2001 | EP0759695A4 A method of inducing an immune response using vaccinia virus recombinants |
| 04/04/2001 | EP0756638B1 Means for treating disorders in the blood coagulation cascade |
| 04/04/2001 | CN1290301A Single-chain bifunctional glycoprotein hormones |
| 04/04/2001 | CN1290299A Process for preparing human proinsulin |
| 04/04/2001 | CN1290270A Streptogramin derivatives prepartion method and compositions containing same |
| 04/04/2001 | CN1290180A Sterile complex of therapeutic peptide bond to polysaccharide |
| 04/04/2001 | CN1290179A Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi |
| 04/04/2001 | CN1290172A Topical composition containing human epidermal growth factor |
| 04/04/2001 | CN1289844A Synergistic enzyme and its preparing process and usage |
| 04/04/2001 | CN1289620A Liquid medicine for radically treating wart |
| 04/04/2001 | CN1289619A Eye drops and its preparing process |
| 04/04/2001 | CN1289618A Health-care polypeptide product for nerve and its preparing process |
| 04/04/2001 | CN1064052C Parathormone related protein human source antibody and its preparation method |
| 04/04/2001 | CN1064051C Calcitonin-like material of solmon and eel without dithio-bond and preparation method |
| 04/04/2001 | CN1064050C Biologic antibiotic peptide, and method for preparing same |
| 04/04/2001 | CN1064049C Thrombopoietin and its producing process |